Remove after-costly-setbacks-astellas-menopause-drug-crosses-fda-finish-line
article thumbnail

After costly setback, Astellas' menopause drug crosses FDA finish line

Fierce Pharma

After costly setback, Astellas' menopause drug crosses FDA finish line zbecker Fri, 05/12/2023 - 16:21

FDA 213